Kamada Chief Financial Officer Chaime Orlev is leaving to pursue other opportunities.
The biopharmaceutical company said Wednesday that Orlev would leave Dec. 31 after serving as finance chief since 2017.
Kamada is currently searching for a successor.
Separately, Kamada said second-quarter revenue rose 23% to $54.9 million.
Profit was $9.3 million, or 16 cents a share, compared with $7.4 million, or 13 cents a share, the year before.
It reiterated its full-year guidance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.